Documente Academic
Documente Profesional
Documente Cultură
INTERNATIONAL CONFERENCE ON
INNOVATIONS AND
FUTURE RESEARCH DIMENSIONS ON
NANOBIO PHARMACEUTICAL TECHNOLOGY
7-8th October, 2014
BOOK OF ABSTRACTS
ORGANIZED BY
DEPARTMENT OF PHARMACEUTICAL TECHNOLOGY
CENTRE FOR EXCELLENCE IN NANOBIO TRANSLATIONAL RESEARCH
BHARATHIDASAN
Organised by: Dept. of Pharma. Tech., & CentreINSTITUTE
for Excellence in OF TECHNOLOGY
Nanobio CAMPUS
Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
TIRUHCIRAPPALLI – 620024, TAMIL NADU, INDIA
VISION AND MISSION
ANNA UNIVERISTY
BHARATHIDASAN INSTITUTE OF TECHNOLOGY CAMPUS
TIRUCHIRAPPALLI – 620024 TAMIL NADU
VISION
To provide quality education, foster research and development in
Pharmaceutical Technology, evolve innovative solutions for industrial
problems and serve for humanity, upraise the department to reach the
apex of glory in pharma education and research to be cognizant of as
Centre for Excellence.
MISSION
Dr.T.SENTHIL KUMAR
Dean, BIT Campus
MESSAGE
The Anna University welcomes all delegates and participants of the DBT & TEQIP II sponsored
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical
Technology (IFRDNBT). Anna University, a largest affiliating unitary type of University in 1978 and
presently offers higher education in Engineering, Technology and allied Sciences relevant to the
current and projected needs of the society as an affiliating Technical University in the state of Tamil
Nadu with its campuses in Tiruchirappalli, Coimbatore, Tirunelveli and Madurai.
We are stepping ahead to become a world-class Technical University and a University of first
choice in India by 2023 as per the vision 2023 statement of Government of Tamil Nadu to become the
knowledge capital and innovation hub in India. We provide education, research, and high quality
consultancy services in engineering and technology that cultivate creativity and innovation; and
therefore, committed to be in the forefront of engineering and technology. Besides teaching and
research, dissemination of knowledge gained therefrom to other associated community is a routine
affair of our University.
Nano and Biotechnology has widespread applications in the drug discovery, development,
delivery with many other promising clinical applications. Significant number of research reports is
being made available recently. Propagation of such knowledge and technologies in the field of nano
and biotechnology for societal and healthcare needs of is of prime priority.
I am confident that this International Conference will review the state of the art and recent
trends in the above technologies for further advancement.
I wish you all an amazing experience in sharing and exchanging ideas and knowledge. I also
congratulate the members of Organizing Committee from the Department of Pharmaceutical
Technology, BIT Campus, Anna University. I also thank the sponsors especially DBT, New Delhi again
for extending support of our noble endeavors!
Best wishes,
(Dr.T.SENTHIL KUMAR)
ANNA UNIVERSITY
BHARATHIDASAN INSTITUTE OF TECHNOLOGY CAMPUS
TIRUCHIRAPPALLI - 620 024
Dr.K.RUCKMANI
Professor and Head, Dept. of Pharma. Tech.,
Director, Centre for Excellence in Nanobio Translational Research
MESSAGE
We want to thank everyone in attendance for convening in Anna University, BIT campus at The
International Conference of Innovations and Future Research Dimensions on Nanobio Pharmaceutical
Technology, to bring together the top nanotechnologists in the world. We are elated to bring together
invited speakers and more than 150 participants from all-around India to disseminate their knowledge
involving nanotechnology and its applications. This meeting aims to provide a platform for researchers from
academia, government, and the pharmaceutical industry to share existing knowledge, vision, technology,
and challenges in the field and promote collaborations among researchers interested in advancing this
fascinating scientific discipline.
We hope to provide insight into many of the valuable applications that nanotechnology has to offer
to the scientific community.
I congratulate the coordinators for their tireless efforts to make this event memorable. My very
best wishes for the conference to be successful and very useful for everyone associated with it.
ANNA UNIVERSITY
BHARATHIDASAN INSTITUTE OF TECHNOLOGY CAMPUS
TIRUCHIRAPPALLI - 620 024
MESSAGE
We would like to personally welcome each of you to the TEQIP II and Department of Biotechnology Sponsored
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology organized
by the Department of Pharmaceutical Technology scheduled during 7-8th October, 2014.
It’s an exciting time for Department of Pharmaceutical Technology, Bharathidasan Institute of Technology Campus
of Anna University as we continue to grow, always adaptable, motivated and responsive to the rapidly changing academic
and research requirements in order to meet the global standards through all possible curricular and co-curricular activities.
Recently our department has been recognized as a Centre for Excellence in Nanobio Translational REsearch (CENTRE) by
the syndicate of Anna University and has created a huge impetus and drive to be more and more responsible in dissemination
of knowledge further fueled by TEQIP and central grants from DST, DRDO, UGC, BRNS & TNSCST for research project
proposals, workshops and seminars.
The world of Nanobio Pharmaceutical Technology is an exciting area in which to learn and to do research studies
etc., and we’ll continue to meet and bring inspired people together in forums like this, to ensure our institution remains
at the cutting edge. We’re transforming the way we operate to continuously improve our ability to translate the nanobio
pharmaceutical technology based research findings in to purposeful products for societal health care needs. Our students
and scholars have continued to meet the challenges of our field and to excel despite setbacks. We are very much proud of
where we are today and excited about where we are headed.
We would like to give you an idea of what you can expect and what we hope to achieve over the next two days.
Firstly, we are honored to have with us as our Chief Guest of today’s event Dr.R.Jayavel, Professor and Director, Centre
for Nanoscience and Technology, Anna University, Chennai, our keynote speakers, Sudeshna Chandra, Visiting Professor,
Technische Universität Chemnitz, Institut für Chemie Lehrstuhl für Anorganische Chemie, Germany, Dr.Vanaja K, Visiting
Scientist, Eberhard Karls Universitat, Tuebingen, Germany, Dr. Sivakumar Gowder, College of Applied Medical Sciences,
Qassim University, KSA and Dr.Gauthaman Karunakaran, College of Pharmacy, College of Medicine, King Khalid University,
Abha, KSA. With their long list of achievements, everybody will be so eager to hear the secrets of their successful research
results and experience gathered in their professional way. They are the people who would be spearheading nanotechnology
research in near future. Apart from the above there are a handsome of research results to be presented by fellow delegates.
The full length research articles submitted by the delegates have been published as Book published by ELSEVIER and Book
of Abstracts in digital format.
Throughout this conference, we ask you to stay engaged, keep us proactive and help us to realize the goals of this
conference and to shape the future of Nanobio Pharmaceutical Technology. Before we close, we would like to thank each
of you for attending our conference and bringing your expertise to our gathering. Our personal respect and thanks goes out
to all of you.
We sincerely thank all the authorities of Anna University for their valuable support and all the sponsors for their
wherewithal for the successful conduct of this conference.
PATRON Dr.S.Ganesan
Registrar, AU, Chennai
ADVISOR Dr.K.Ruckmani
Prof & Head
Dept. of Pharm. Tech., AU-BIT
COORDINATOR Dr.S.Latha
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Dr.P.Selvamani
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
MEMBERS Dr.A.Puratchikody
Professor
Dept. of Pharm. Tech., AU-BIT
Dr.N.Subramanian
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Dr.E.Sanmugapriya
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Dr.R.Vijaya
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Mr.A.Shanmugarathinam
Assistant Professor
EDITORIAL BOARD CHAIRPERSON
Dept. of Pharm. Tech., AU-BIT
Mrs.A.Umamaheswari
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Mr.R.Suriyakanth
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Dr.P.SenthamilSelvan
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Mrs.K.Akilandeshwari
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Dr.K.Kavitha
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Dr.S.Lakshmanaprabu
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
Mrs.K.Vijayalakshmi
Assistant Professor
Dept. of Pharm. Tech., AU-BIT
EDITORIAL Mr.C.Prabu
BOARD Research Scholar
MEMBERS Dept. of Pharm. Tech., AU-BIT
Mrs.M.ArputhaBibiana
Research Scholar
Dept. of Pharm. Tech., AU-BIT
Ms.P.S. Dhivya
Research Scholar
Dept. of Pharm. Tech., AU-BIT
Mr.S.Rajkumar
Research Scholar
Dept. of Pharm. Tech., AU-BIT
Mrs.M.Poornima
Research Scholar
Dept. of Pharm. Tech., AU-BIT
C.SHERLINA DAPHNY M.Tech., Final Year
Dept. of Pharm. Tech., AU-BIT
TABLE OF CONTENTS
NANOMATERIALS (ORAL)
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
NM-OP-21 Phytogenic synthesis of silver nanoparticles and its potential for on blue 21
dye decolorization
P. Balashanmugam
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
NANOMATERIALS (POSTER)
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
BIOTECHNOLOGY (ORAL)
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
BT-OP-07 Packed bed column adsorption of cr (vi) onto acid treated Codium 63
tomentosum biomass
P. Suresh Babu
BIOTECHNOLOGY (POSTER)
BT-PP-01 Biological control of damping off and stem rot of tomato (Lycopersicon 65
esculentum Mill.) using an antagonistic actinomycete,
Saccharopolyspora erythraea.
S.B.Prabha
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
PT-PP-06 Energy management and integration of PEM fuel cell with UAV for 96
pharmaceutical application
Dr.N.Stalin
PT-PP-07 A review on animal models involved drug discovery pipeline for the 97
alzheimer disease
R.Benaseer Begam
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
PT-PP-11 Synthetic and Biological Evaluation of natural Proline rich peptide 101
Rajiv Dhiya
PT-PP-13 Dendrimers based targeted drug delivery of rivastigmine for treatment 103
of Alzheimer’s disease
Krishna Reddy
DD-OP-02 Design and in-vitro evaluation of gliclazide loaded transdermal drug 106
delivery therapeutic system containing HPMC and PVP
V.Raghuraman
DD-OP-03 Formulation and in-vitro evaluation of self- emulsifying drug delivery 107
system of carbamazepine
Chinmay Vora Swati Saxena
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology
DD-PP-02 Modified release multiparticulate delivery system for tramadol HCl 111
using gelucire 43/01 as rate retarding material
S.Divya Priya
Organised by: Dept. of Pharma. Tech., & Centre for Excellence in Nanobio Translational Research,
Anna University, BIT Campus, Tiruchirappalli - 620024
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
1
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Keywords: Herbal mediated silver nano particles (SNPs), Gymnema sylvestre Linn, SEM, EDAX, FT-
IR, UV, X-ray diffraction, PSA and TGDTA.
2
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
3
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
4
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Nanocomposite film (1) physical appearance (2) Light Microscopic view (40X)
5
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
6
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
7
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Keywords: Murraya paniculata, X-ray diffraction analysis, vascular endothelial growth factor.
8
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
50
40 Cs-Ag NPS
30
As-Ag NPs
20
10
0
50 100 150 200 250
Concentration (µg/mL)
Fig 1: Hemolytic activity of green and chemically synthesized Silver nanoparticles
Fig 2: SEM Analysis of green synthesized Silver nanoparticles (As-Ag NPs)
9
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
MIC of pure TNZ (A2), Lyophilized NPs (B2) and blank NPs (C2).
10
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
11
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
12
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
13
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
14
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
15
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
16
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
17
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
18
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
TEM image of AGNPs AO/EB staining of MCF cell line treated with AGNPs
19
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
A NOVEL FENUGREEK DERIVED VICENIN-2 GOLD NANOPARTICLES AND ITS GLUCOSE UPTAKE N
EFFECT IN 3T3-L1 ADIPOCYTES
A
C. Shivashri, T. Rajarajeshwari, P. Rajasekar
Department of Biotechnology, Rajalakshmi Engineering College, Thandalam, Chennai-602 105, Tamil Nadu N
Email id: shivashri.cj@gmail.com, rajarajeshwari.t@gmail.com O
M
The anti-diabetic property of bioactive constituents of fenugreek has been well A
established. Thus, the study synthesized gold nanoparticles using Vicenin-2, a C-glucoside T
flavonoid of fenugreek. The biosynthesized vicenin-2 gold nanoparticles (V-AuNPs) were E
confirmed primarily by its color transformation and UV absorption. The size and shape, crystalline R
nature and stability of V-AuNPs were examined under TEM, XRD and FT-IR analysis respectively. I
The bio-reducing efficiency of vicenin-2 was computed. The stability of V-AuNPs in various A
physiological medium (10% NaCl, 0.5% BSA, 0.2 M Histidine & 0.2 M Cysteine) and different pH
L
(1.2, 5, 7.4 & 9) was explored. The cytotoxicity and glucose uptake assays were also performed
S
in 3T3-L1 adipocytes. The appearance of yellowish orange color and UV absorption at 537 nm
confirmed the formation of V-AuNPs. The V-AuNPs showed a spherical morphology with a size of
57 nm and appeared as face centered cubic (fcc) crystals under TEM and XRD analysis
respectively. The FT-IR spectra of plain Vicenin-2 and its gold nanoparticles confirmed functional
groups responsible for the biosynthesis of V-AuNPs. The reducing potential of Vicenin-2 was
found to be 97.5%. The V-AuNPs showed a remarkable stability in different physiological medium
and in buffers of different pH. The IC-50 value for V-AuNPs was found to be 119 µg/µL. A
concentration dependent rise in glucose uptake was noted in 3T3-L1 adipocytes on treatment
with V-AuNPs. The study suggests that V-AuNPs would serve as a novel nano-based bio-drug for
the management of diabetes.
20
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
PHYTOGENIC SYNTHESIS OF SILVER NANOPARTICLES AND ITS POTENTIAL FORON BLUE DYE N
DECOLORIZATION
A
P. Balashanmugam1*, P. Arthi 2 and P.T Kalaichelvan3
1
Centre for Advanced Studies in Botany, University of Madras, Chennai 600 025, India N
2
Department of Inorganic Chemistry, University of Madras, Chennai 600 025, India O
M
3
ALKA Research Foundation, Coimbatore, 641 046, India
Email id: biobala17@gmail.com, 91+9994633730
A
T
Textile industries are the major users of dyes in the world. A huge fraction of dyes are
E
discharged out from the textile industries, causing serious damage to the environment.
R
Nanotechnology based technologies has been proved to be the most attractive and cost-
effective method to counter textile dye pollution. The ability of the Silver nanoparticles (Ag NPs) I
to decolorize dyes the textile dyes has been investigated. A novel bio approach for the synthesis A
and stabilization of Ag NPs using aqueous extract of Cassia roxburghii leaves under ambient L
conditions. The instant formation of Ag NPs was analyzed by visual observation and UV–visible S
spectrophotometer. The synthesized Ag NPs were characterized by HR-TEM with EDX and XRD.
Appearance of dark brownish color confirmed the formation of Ag NPs. Phytoconstituents
present in the plant extract might have helped in the reduction and capping agent of Ag NPs. The
XRD and EDX pattern of synthesized Ag NPs showed their crystalline structure with face centered
cubic and silver metals are present in the nanoparticles. HR-TEM studies exposed that the
diameter of stable Ag NPs was approximately 40 nm. These particles were then checked for their
efficiency to decolorize the textile dye foron blue. The Ag NPs are observed to be have a good
catalytic activity on the reduction of foron blue. The nanoparticles treated effluent was tested on
seed germination and growth of green gram. The treated dyes also improved seed germination
and growth of green gram when compared to the untreated dyes. This indicated the non- toxicity
of the Ag NPs decolorized dye effluent respectively.
21
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Average particle size of the nanoparticles Loaded Antifungal activity of treated cotton fabrics – Soil uri
with S.dulcis leaf extract
22
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
23
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Bacterial reduction activity of polycotton fabric treated with A. paniculata loaded nanoparticles.
24
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
25
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
26
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
27
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
28
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
29
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
30
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
31
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
32
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
33
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
34
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Graphical representation of effect of selected factors (X) using Length’s methods; (a) and
Bayesian analysis (b)
35
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
36
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
37
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
38
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
IC50 (µg/ml)*
Cell lines studied
NiO-Ace Cisplatin
NHDF (Normal Human Dermal Fibroblasts) 27.95 4.45
HeLa (Human Cervical Cancer Cells) 15.28 1.15
MCF7 (Human Breast Cancer Cells) 11.46 1.6
HepG2 (Human Liver Cancer cells) 27.72 2.87
A-549 (Human Lung Cancer Cells) 28.39 3.12
39
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
R 4'
5' 3'
6' 2'
O 1'
4
5 3
R1 NH
2
6 X
H3C N1
H
40
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
130
PBS
110
SGF
cumulative % release
90 SIF
70
50
30
10
0 2 4 6 8 10 12
Time (hr)
41
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
42
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
43
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
44
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
45
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Size of the nanoparticles loaded with Antibacterial assessment of the treated fabric against
combinatorial herbal extract S.marcescens and S.aureus
46
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
47
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
48
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
49
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
50
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Clitoria ternatea
51
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
52
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
53
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
54
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
55
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
56
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Results of phytochemical analysis of stem of Artemisia nilagirica (Clarke) Pamp with water
solvent
57
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
58
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
59
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
60
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
61
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Effect of microbes on the colour, TDS and COD removal from the sugar wash (96 hrs)
Sl No Microorganism Colour Removal % TDS Reduction % COD Reduction %
1 Enterobacter(T1) sp. 6 9 13
2 Corynebacterium(T2) sp. 9 12.76 14
3 Microccocus(T3) sp. 6 9.2 13
4 Corynebacterium(T4) sp. 8 12 16
5 Consortia 28 32 35
62
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
PACKED BED COLUMN ADSORPTION OF CR (VI) ONTO ACID TREATED CODIUM TOMENTOSUM
B
BIOMASS
P. Suresh Babu1, S. Eswaramoorthi2, T.P. Rajesh3 and B. Anandaraj4 I
1
Department of Biotechnology, Sree Sastha Institute of Engineering and Technology,Chembarambakkam, O
Chennai–600123, TN 2Department of Civil Engineering, BIT Campus, Anna University,Tiruchirappalli–620024, TN T
3, 4
Department of Biotechnology, BIT Campus, Anna University, Tiruchirappalli–620024, TN E
Email id: dranandaraj74@gmail.com, Mob: 9790915036
C
H
Packed bed column study was conducted by using acid activated Codium tomentosum
biomass for the adsorption of chromium (VI) from aqueous solution. SEM analysis was carried N
out to study the surface topology of the biomass and SEM micrographs are subjected to fractal O
analysis to examine the surface roughness and porosity of the biomass. The influence of bed L
depth and flow rate was investigated. The breakthrough curves obtained for the experimental O
data elucidate the importance of bed depth and flow rate. To evaluate the adsorption column G
performance, Bohart-Adam’s, BDST, Thomas and Yoon–Nelson model was used. BDST Model Y
expressed the good linearity for the experimental data. Linear regression coefficients (R2 values)
of Thomas and Yoon–Nelson model showed a good linearity when compared with Bohart-Adam
model. The potential of the acid treated Codium tomentosum biomass in the removal of
chromium (VI) was found to be good. Hence, it was concluded that acid treated Codium
tomentosum biomass can be used as an effective adsorbent for the removal of chromium (VI)
ions.
Keywords: Codium tomentosum, Cr (VI) removal, Column studies, Fractal analysis, Acid
activation.
Bed height Flow rate Uptake capacity tb (h) te (h) ∆t (h) Cr(VI) Removal
(cm) (mg/ml) (mg/g) percentage
4 2 24.40 7 33 26 80.54
6 2 21.64 9 40 31 83.47
8 2 17.67 9 41 32 80.70
10 2 15.44 14 46 32 83.54
10 4 14.20 8 23 15 81.43
Column data and parameters obtained at different flow rates and bed heights
63
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
64
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
65
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
66
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
67
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
7
B.subtilis
6
M.luteus
5
S.aureus
4
E.coli
3
P.aeruginosa
2
k.pneumoniae
1
0
68
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
69
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Keywords: - Carica papaya, Aloe vera gel, citric acid, tartaric acid, PLW (Physiological Loss of
Weight).
60 Control
40 AGI
20 AGII
0
5 10
STORAGE DAYS
70
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Schematic representation of the study: Ion Sensitive Field Effect Transistor for detection of microbial biofilm
formation
71
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
72
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
73
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
150
C
100
NDH
50
DH
0
Showed comparison the mean ± SEM lipid profiles (mg/dl) of controls(C) and both non
diabetic with hyperlipidemia (NDH) and diabetic with hyperlipidemia (DH) subjects
74
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Summary of Mean percent of blood glucose reduction (mg/dL) in Rats (Normal & Diabetic) and Rabbits
75
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
76
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
77
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
78
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
79
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Changes in disease activity index were evaluated daily throughout the 7-day experimental period. Values
are expressed as mean±SEM of three independent experiments. ### P<0.001 acetic acid colitis group
compared with the normal control group. AML (0.65mg/kg), AML (1.3mg/kg) and Prednisolone (5mg/kg)
shows significantly decrease DAI compared with the acetic acid induced colitis group
80
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
81
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
82
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
83
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
60
50
40
30
Glucosidase
20
amylase
10
0
15.62
500
1.95
7.81
125
250
62.5
1000
31.25
3.9
Concentration
. (a)Myxopyrum serratulum A. H. Hill flower, (b) Inhibitory activity of Myxopyrum serratulum on α-amylase
and α-glucosidase enzymes
84
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
85
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
86
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
87
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
88
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
89
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
90
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Antibacterial activity of AgNPs against clinical pathogens (A) P.aeruginosa,(B) K.pneumoniae, (C) S.aureus
(D) E.faecalis, (E) E.coli and (F) P.vulgaris. (Disc Diffusion Method)
91
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
92
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
80 Form E
Form D
60 Commercial form
Form S
40 Form G
Form C
20
0
0 50 100 150 200
. In vitro dissolution of Pioglitazone polymorphs
93
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
94
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
95
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
96
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
97
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
98
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
99
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
100
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
101
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
102
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
103
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
104
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
105
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
106
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Pseudo – ternary phase diagrams of various ratios of oil to Composition of optimized formulations
surfactant/cosurfactant A (1:1) , B (1:2) , C(1:3) of Carbamazepine SMEDD
107
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
108
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
Semlogarithmic plot of mean plasma enrofloxacin and Atomic force microscopic image of enrofloxacin
its metabolite ciprofloxacin concentration (µg/mL) vs. SLNs
time in emus (n=8) following administration of native
enrofloxacin and enrofloxacin SLNs (10mg/kg).
109
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
110
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
IR spectrum of Tramadol HCl, FT-IR analysis of the Gelucire 43/01, FT-IR analysis of the Formulation (F1)
111
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
112
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
113
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
114
International Conference on Innovations and Future Research Dimensions on Nanobio Pharmaceutical Technology, 7-8th October, 2014
115
SPONSORS
COOLING CENTRIFUGE FREEZE DRYER ICE FLAKE MACHINE DEEP FREEZER
ORBITAL SHAKER INCUBATOR SHAKER 4 SIDE GLASS INCUBATOR SHAKER REFRIGERATED SHAKER
LARGER CAPACITY SHAKER PLANT GROWTH /STABILITY CHAMBER FERMENTOR INSITU & AUTOCLAVABLE VESSELS
SINGLE DISTILLATION UNIT PH/CON BENCH TOP METER SONICATOR PROBE TYPE PCR-THERMAL CYCLER
...to rodents
freely moving, restrained, anesthetized
MCP 100
The smallest benchtop polarimeter with top features
4 Smart & small:
Save space in your lab with the „A3-page“ footprint